ReP USP - Resultado da busca

Artigo de periodico
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? (2020)
Costa, Luís Henrique Angenendt da; Santos, Bruna Maitan; Branco, Luiz Guilherme de Siqueira
Fonte: European Journal of Pharmacology. Unidades: FORP, FMRP
Assuntos: SEROTONINA, CITOCINAS, COVID-19, INFLAMAÇÃO, FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Luís Henrique Angenendt da e SANTOS, Bruna Maitan e BRANCO, Luiz Guilherme de Siqueira. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?. European Journal of Pharmacology, v. 889, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173629. Acesso em: 02 nov. 2024.
APA
Costa, L. H. A. da, Santos, B. M., & Branco, L. G. de S. (2020). Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? European Journal of Pharmacology, 889, 1-7. doi:10.1016/j.ejphar.2020.173629
NLM
Costa LHA da, Santos BM, Branco LG de S. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? [Internet]. European Journal of Pharmacology. 2020 ; 889 1-7.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173629
Vancouver
Costa LHA da, Santos BM, Branco LG de S. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? [Internet]. European Journal of Pharmacology. 2020 ; 889 1-7.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173629
Artigo de periodico
Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine (2010)
Jacob-Ferreira, Anna Laura Bechara; Palei, Ana Carolina Taveiros; Izidoro-Toledo, Tatiane de Carvalho; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo; Cáu, Stêfany Bruno de Assis; Moreno Junior, Heitor; Martinez, Márcio Luís Lombardi
Fonte: European Journal of Pharmacology. Unidades: FORP, FMRP
Assuntos: METALOPROTEINASES, ENDOTÉLIO VASCULAR, FUMO (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOB-FERREIRA, Anna Laura Bechara et al. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine. European Journal of Pharmacology, v. 627, n. 1-3, p. 216-222, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2009.10.057. Acesso em: 02 nov. 2024.
APA
Jacob-Ferreira, A. L. B., Palei, A. C. T., Izidoro-Toledo, T. de C., Gerlach, R. F., Tanus-Santos, J. E., Cáu, S. B. de A., et al. (2010). Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine. European Journal of Pharmacology, 627( 1-3), 216-222. doi:10.1016/j.ejphar.2009.10.057
NLM
Jacob-Ferreira ALB, Palei ACT, Izidoro-Toledo T de C, Gerlach RF, Tanus-Santos JE, Cáu SB de A, Moreno Junior H, Martinez MLL. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine [Internet]. European Journal of Pharmacology. 2010 ; 627( 1-3): 216-222.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2009.10.057
Vancouver
Jacob-Ferreira ALB, Palei ACT, Izidoro-Toledo T de C, Gerlach RF, Tanus-Santos JE, Cáu SB de A, Moreno Junior H, Martinez MLL. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine [Internet]. European Journal of Pharmacology. 2010 ; 627( 1-3): 216-222.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2009.10.057
Artigo de periodico
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats (2008)
Martinez, Marcio L. L.; Castro, Michele M.; Rizzi, Elen; Fernandes, Karla; Demacq, Caroline; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Fonte: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP
Assuntos: HIPERTENSÃO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 02 nov. 2024.
APA
Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096
NLM
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Vancouver
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Artigo de periodico
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats (2008)
Martinez, Marcio L. L.; Rizzi, Elen; Castro, Michele M.; Fernandes, Karla; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Fonte: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP
Assuntos: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 02 nov. 2024.
APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007
NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
Artigo de periodico
Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats (2004)
Del Bel, Elaine Aparecida; Silva, Célia Aparecida da; Guimarães, Francisco Silveira; Bermúdez Echeverry, Marcela
Fonte: European Journal of Pharmacology. Unidades: FORP, FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEL BEL, Elaine Aparecida et al. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. European Journal of Pharmacology, v. 125, p. 175-181, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2003.11.071. Acesso em: 02 nov. 2024.
APA
Del Bel, E. A., Silva, C. A. da, Guimarães, F. S., & Bermúdez Echeverry, M. (2004). Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. European Journal of Pharmacology, 125, 175-181. doi:10.1016/j.ejphar.2003.11.071
NLM
Del Bel EA, Silva CA da, Guimarães FS, Bermúdez Echeverry M. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats [Internet]. European Journal of Pharmacology. 2004 ; 125 175-181.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2003.11.071
Vancouver
Del Bel EA, Silva CA da, Guimarães FS, Bermúdez Echeverry M. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats [Internet]. European Journal of Pharmacology. 2004 ; 125 175-181.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2003.11.071
Artigo de periodico
Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats (2004)
Perry, Juliana Cini; Da Cunha, Claudio; Anselmo-Franci, Janete Aparecida; Andreatini, Roberto; Miyoshi, Edmar; Tufik, Sérgio; Vital, Maria A. B. F.
Fonte: European Journal of Pharmacology. Unidade: FORP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERRY, Juliana Cini et al. Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats. European Journal of Pharmacology, v. 484, p. 225-233, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2003.11.029. Acesso em: 02 nov. 2024.
APA
Perry, J. C., Da Cunha, C., Anselmo-Franci, J. A., Andreatini, R., Miyoshi, E., Tufik, S., & Vital, M. A. B. F. (2004). Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats. European Journal of Pharmacology, 484, 225-233. doi:10.1016/j.ejphar.2003.11.029
NLM
Perry JC, Da Cunha C, Anselmo-Franci JA, Andreatini R, Miyoshi E, Tufik S, Vital MABF. Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats [Internet]. European Journal of Pharmacology. 2004 ; 484 225-233.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2003.11.029
Vancouver
Perry JC, Da Cunha C, Anselmo-Franci JA, Andreatini R, Miyoshi E, Tufik S, Vital MABF. Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats [Internet]. European Journal of Pharmacology. 2004 ; 484 225-233.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2003.11.029
Artigo de periodico
Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway (2003)
Almeida, Maria Camila; Pelá, Irene Rosemir; Branco, Luiz Guilherme de Siqueira
Fonte: European Journal of Pharmacology. Unidades: FCFRP, FORP
Assuntos: FEBRE, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Maria Camila e PELÁ, Irene Rosemir e BRANCO, Luiz Guilherme de Siqueira. Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway. European Journal of Pharmacology, v. 467, p. 133-140, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0014-2999(03)01636-4. Acesso em: 02 nov. 2024.
APA
Almeida, M. C., Pelá, I. R., & Branco, L. G. de S. (2003). Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway. European Journal of Pharmacology, 467, 133-140. doi:10.1016/s0014-2999(03)01636-4
NLM
Almeida MC, Pelá IR, Branco LG de S. Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway [Internet]. European Journal of Pharmacology. 2003 ; 467 133-140.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/s0014-2999(03)01636-4
Vancouver
Almeida MC, Pelá IR, Branco LG de S. Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway [Internet]. European Journal of Pharmacology. 2003 ; 467 133-140.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/s0014-2999(03)01636-4
Artigo de periodico
Serotonin modulation of catalepsy induced by 'N POT.G'-nitro-L-arginine in mice (1999)
Nucci-da-Silva, Leopoldo P.; Guimarães, Francisco Silveira; Del Bel, Elaine Aparecida
Fonte: European Journal of Pharmacology. Unidades: FMRP, FORP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUCCI-DA-SILVA, Leopoldo P. e GUIMARÃES, Francisco Silveira e DEL BEL, Elaine Aparecida. Serotonin modulation of catalepsy induced by 'N POT.G'-nitro-L-arginine in mice. European Journal of Pharmacology, v. 379, p. 47-52, 1999Tradução . . Acesso em: 02 nov. 2024.
APA
Nucci-da-Silva, L. P., Guimarães, F. S., & Del Bel, E. A. (1999). Serotonin modulation of catalepsy induced by 'N POT.G'-nitro-L-arginine in mice. European Journal of Pharmacology, 379, 47-52.
NLM
Nucci-da-Silva LP, Guimarães FS, Del Bel EA. Serotonin modulation of catalepsy induced by 'N POT.G'-nitro-L-arginine in mice. European Journal of Pharmacology. 1999 ; 379 47-52.[citado 2024 nov. 02 ]
Vancouver
Nucci-da-Silva LP, Guimarães FS, Del Bel EA. Serotonin modulation of catalepsy induced by 'N POT.G'-nitro-L-arginine in mice. European Journal of Pharmacology. 1999 ; 379 47-52.[citado 2024 nov. 02 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em